
Oncology Ventures is a venture capital firm founded by Ben Freeberg that invests in healthcare data and AI startups enhancing cancer care and research. The firm focuses on data-driven technologies across early detection, precision diagnostics, care navigation, and non-drug infrastructure.
48% of their portfolio is in Healthcare. Deal activity decreased year-over-year (4 deals in the last 12 months vs 6 prior). Average disclosed round size is $10.1M (across 16 rounds with reported amounts).
Portfolio
14
Fund Size
$62M
Top Stage
Series A
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
21 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | — | Mar 2026 | |
| Series A | — | Jan 2026 | |
| RRisa Labs | Series A | $11.1M | Jan 2026 |
| Series A | $10M | Nov 2025 | |
| Series B | — | Nov 2025 | |
| Series A | $20M | Sep 2025 | |
| DDaymark | Series A | $20M | Sep 2025 |
| Series A | — | Aug 2025 | |
| Seed | $3.5M | Apr 2025 | |
| DDaymark | Seed | $11.5M | Apr 2025 |
| Seed | $11.5M | Apr 2025 | |
| Series A | $10M | Jan 2025 | |
| DDaymark | Series A | $20M | Jan 2025 |
| OOncoverycare | Seed | $4.5M | May 2024 |
| MmPATH | Growth | $1M | Jan 2024 |
| Pre-Seed | — | Jan 2023 | |
| Seed | $4.5M | — | |
| Seed | $3.5M | — | |
| Series B | $22M | — | |
| RRisa Labs | Seed | $3.5M | — |
| Unknown | $4.5M | — |
Top Co-Investors
z21 Ventures5 shared
Maverick Ventures5 shared
Yosemite5 shared
General Catalyst3 shared
Optum Ventures3 shared
F-Prime Capital3 shared
Fidelity Investments3 shared
The Blue Venture Fund3 shared
Healthier Capital3 shared
Cencora Ventures2 shared
Wittington Ventures2 shared
Sandbox Industries2 shared
Techstars2 shared
.406 Ventures2 shared
Investible2 shared
Labcorp1 shared
SpringTide1 shared
FCA Venture Partners1 shared
University of Chicago1 shared
Brandon Capital1 shared
Last updated: 20 October 2026